Parkinson’s Disease Drugs Market Report

Global and China Parkinson’s Disease Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 17, 2022
  • PAGES：223
  • REPORT CODE：GMM1382570
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Parkinson’s Disease Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Valeant Pharmaceuticals International

    • Impax Laboratories

    • F Hoffmann-La Roche

    • GlaxoSmithKline

    • STADA Arzneimittel

    • UCB Inc

    • Merck

    • Teva Pharmaceutical Industries

    • AbbVie

    • Novartis

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral

    • Transdermal

    • Subcutaneous

    • Intestinal Infusion

    Application:

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Parkinson’s Disease Drugs Industry Overview

      • 1.1.1 Parkinson’s Disease Drugs Market Scope and Market Segments

      • 1.1.2 Parkinson’s Disease Drugs Industry Characteristics

      • 1.1.3 Global and China Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Parkinson’s Disease Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Parkinson’s Disease Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral

      • 1.2.2 Transdermal

      • 1.2.3 Subcutaneous

      • 1.2.4 Intestinal Infusion

    • 1.3 Global Parkinson’s Disease Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacy

      • 1.3.2 Retail Pharmacy

      • 1.3.3 Online Pharmacy

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Parkinson’s Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Parkinson’s Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Parkinson’s Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Parkinson’s Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Parkinson’s Disease Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Parkinson’s Disease Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Parkinson’s Disease Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Parkinson’s Disease Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Parkinson’s Disease Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Parkinson’s Disease Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Parkinson’s Disease Drugs Industry PEST Analysis

    • 2.3 Parkinson’s Disease Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Parkinson’s Disease Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Parkinson’s Disease Drugs Industry

    Chapter 3 Global and China Parkinson’s Disease Drugs Market, by Manufacturer

    • 3.1 Global and China Parkinson’s Disease Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Parkinson’s Disease Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Parkinson’s Disease Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Parkinson’s Disease Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Parkinson’s Disease Drugs Market Top 3 Players

    Chapter 4 Global and China Parkinson’s Disease Drugs Market, by Type (2017-2028)

    • 4.1 Parkinson’s Disease Drugs Market Trend, by Type

    • 4.2 Global Parkinson’s Disease Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Parkinson’s Disease Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Parkinson’s Disease Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Parkinson’s Disease Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Parkinson’s Disease Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Parkinson’s Disease Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Parkinson’s Disease Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Parkinson’s Disease Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Parkinson’s Disease Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Parkinson’s Disease Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Parkinson’s Disease Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Parkinson’s Disease Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Parkinson’s Disease Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Parkinson’s Disease Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Parkinson’s Disease Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Parkinson’s Disease Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Parkinson’s Disease Drugs Market Analysis

    • 7.1 North America Parkinson’s Disease Drugs Market, by Type

    • 7.2 North America Parkinson’s Disease Drugs Market, by Application

    • 7.3 North America Parkinson’s Disease Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Parkinson’s Disease Drugs Market Analysis

    • 8.1 Europe Parkinson’s Disease Drugs Market, by Type

    • 8.2 Europe Parkinson’s Disease Drugs Market, by Application

    • 8.3 Europe Parkinson’s Disease Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Parkinson’s Disease Drugs Market Analysis

    • 9.1 APAC Parkinson’s Disease Drugs Market, by Type

    • 9.2 APAC Parkinson’s Disease Drugs Market, by Application

    • 9.3 APAC Parkinson’s Disease Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Parkinson’s Disease Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Parkinson’s Disease Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Parkinson’s Disease Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Parkinson’s Disease Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Parkinson’s Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Parkinson’s Disease Drugs Company Profiles

      • 11.1 Valeant Pharmaceuticals International

        • 11.1.1 Valeant Pharmaceuticals International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Valeant Pharmaceuticals International Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.1.3 Valeant Pharmaceuticals International Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Impax Laboratories

        • 11.2.1 Impax Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Impax Laboratories Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.2.3 Impax Laboratories Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 F Hoffmann-La Roche

        • 11.3.1 F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 F Hoffmann-La Roche Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.3.3 F Hoffmann-La Roche Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 GlaxoSmithKline

        • 11.4.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 GlaxoSmithKline Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.4.3 GlaxoSmithKline Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 STADA Arzneimittel

        • 11.5.1 STADA Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 STADA Arzneimittel Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.5.3 STADA Arzneimittel Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 UCB Inc

        • 11.6.1 UCB Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 UCB Inc Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.6.3 UCB Inc Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Merck

        • 11.7.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Merck Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.7.3 Merck Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Teva Pharmaceutical Industries

        • 11.8.1 Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Teva Pharmaceutical Industries Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.8.3 Teva Pharmaceutical Industries Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 AbbVie

        • 11.9.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 AbbVie Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.9.3 AbbVie Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Novartis

        • 11.10.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Novartis Parkinson’s Disease Drugs Product Profiles, Application and Specification

        • 11.10.3 Novartis Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Parkinson’s Disease Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Parkinson’s Disease Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Parkinson’s Disease Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Parkinson’s Disease Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Market Size and Growth Rate of Transdermal (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Market Size and Growth Rate of Subcutaneous (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Market Size and Growth Rate of Intestinal Infusion (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Market Size and Growth Rate of Hospital Pharmacy (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Market Size and Growth Rate of Retail Pharmacy (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Market Size and Growth Rate of Online Pharmacy (2017-2028)

    • Figure North America Parkinson’s Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Parkinson’s Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Parkinson’s Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson’s Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Parkinson’s Disease Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Parkinson’s Disease Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Parkinson’s Disease Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Parkinson’s Disease Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Parkinson’s Disease Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Parkinson’s Disease Drugs Market Share, by Manufacturer in 2022

    • Table Global Parkinson’s Disease Drugs Sales Volume, by Type (2017-2028)

    • Table Global Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Parkinson’s Disease Drugs Sales Value, by Type (2017-2028)

    • Table Global Parkinson’s Disease Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Price Trend, by Type (2017-2028)

    • Table China Parkinson’s Disease Drugs Sales Volume, by Type (2017-2028)

    • Table China Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Parkinson’s Disease Drugs Sales Value, by Type (2017-2028)

    • Table China Parkinson’s Disease Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Parkinson’s Disease Drugs Price Trend, by Type (2017-2028)

    • Table Global Parkinson’s Disease Drugs Sales Volume, by Application (2017-2028)

    • Table Global Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Parkinson’s Disease Drugs Sales Value, by Application (2017-2028)

    • Table Global Parkinson’s Disease Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Parkinson’s Disease Drugs Sales Value Share, by Application (2017-2028)

    • Table China Parkinson’s Disease Drugs Sales Volume, by Application (2017-2028)

    • Table China Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Parkinson’s Disease Drugs Sales Value, by Application (2017-2028)

    • Table China Parkinson’s Disease Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson’s Disease Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Parkinson’s Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Parkinson’s Disease Drugs Sales Volume, by Type (2017-2028)

    • Table North America Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Parkinson’s Disease Drugs Sales Volume, by Application (2017-2028)

    • Table North America Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Parkinson’s Disease Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Parkinson’s Disease Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Parkinson’s Disease Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Parkinson’s Disease Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson’s Disease Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson’s Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson’s Disease Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson’s Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Parkinson’s Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Parkinson’s Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Table Valeant Pharmaceuticals International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharmaceuticals International Product Profiles, Application and Specification

    • Table Valeant Pharmaceuticals International Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Impax Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Impax Laboratories Product Profiles, Application and Specification

    • Table Impax Laboratories Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table STADA Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table STADA Arzneimittel Product Profiles, Application and Specification

    • Table STADA Arzneimittel Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table UCB Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table UCB Inc Product Profiles, Application and Specification

    • Table UCB Inc Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Industries Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Industries Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Parkinson’s Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US